FBTIX Mutual Fund

FBTIX Mutual Fund (Fidelity Advisor Biotechnology Fund Class I) is managed by Fidelity Investments (US) with $985.1M in net assets. FBTIX expense ratio is 0.69%, holding 131 positions across sectors including Health Care, Financials, Industrials. Inception date: 2000-12-27.

FBTIX performance shows a YTD return of 29.60%. The 1-year return is 35.74% and the 5-year return is 13.29%. FBTIX dividend yield stands at 0.89%, paid annually.

FBTIX top holdings include Abbvie Inc. (13.8%), Gilead Sciences (6.0%), Alnylam Pharmaceuticals Inc. (3.8%), Insmed Inc (3.4%), Amylyx Pharmaceuticals Inc (3.4%). Go to all FBTIX holdings, FBTIX sectors, or FBTIX dividends.

FBTIX can be compared against other funds. Use FBTIX overlap to find shared positions, or FBTIX vs another fund for a side-by-side view. FBTIX alternatives are available via the screener, along with tax-loss harvesting opportunities.